Investor · Columbus, OH

Stonehenge Partners Corp

Open Stonehenge in the network graph →

Filings

10

SEC Form D

Connections

51

co-filers

Capital

$261.2M

across filings

Active

Mar 2021

to Sep 2023

Most-connected co-filers (51)

(General Partner) Poplar Forest Capital LLC · Pasadena, CA7 shared Andrew T. Hunter · Vancouver, British Columbia, Canada6 shared David T. Rosenthal · Santa Monica, CA6 shared David Smalley · New York, NY6 shared Christopher Conway · San Francisco, CA6 shared Ronan D. Levy · Toronto, Ontario, Canada6 shared Brian B. Strom · DOVER, DE5 shared Michael C. Brown, Jr · East Brunswick, NJ5 shared Andrew Kaip · Toronto, Ontario, Canada5 shared Andrew F. Bohutinsky · Columbus, OH4 shared Rochael Adranly · San Francisco, CA4 shared Philippe J. Lespinard · George Town, Grand Cayman, Cayman Islands4 shared Hanny D. Kanafani · Los Alamos, NM4 shared Colin Steen · Arlington, VA4 shared Peter G. Davies · Columbus, OH4 shared Jack Mitchell · Gladstone, MO4 shared Thomas R. Utgard · Columbus, OH4 shared Sid Gorham · Emeryville, CA3 shared Karla J. Bodden · Grand Cayman, Cayman Islands3 shared Charles M. Lieser · Fort Worth, TX2 shared Robert Ruffolo · Monmouth Junction, NJ2 shared Paul M. Salisbury · San Antonio, TX2 shared Halden H. Conner · Forth Worth, TX2 shared Scott C. Rose · Dover, DE2 shared

Recent filings (10)

Trait Biosciences Inc.Sep 2023 · 11 co-filers$3.7M Stonehenge Opportunity Fund V, LPMar 2023 · 16 co-filers Trait Biosciences Inc.Nov 2022 · 17 co-filers$230K Trait Biosciences Inc.Nov 2022 · 17 co-filers$102K Trait Biosciences Inc.Nov 2022 · 14 co-filers$210K Stonehenge Opportunity Fund V, LPMar 2022 · 16 co-filers Nacuity Pharmaceuticals, Inc.Jan 2022 · 20 co-filers$17.4M Trait Biosciences Inc.Oct 2021 · 14 co-filers$619K Trait Biosciences Inc.Mar 2021 · 14 co-filers$12.1M Nacuity Pharmaceuticals, Inc.Mar 2021 · 20 co-filers$11.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Stonehenge in the interactive graph →